Omada Health

About Omada Health

Omada Health is one of the most established digital health companies in the United States, founded in 2011 — years before GLP-1 medications became a cultural phenomenon. The company built its reputation on its CDC-recognized Diabetes Prevention Program (DPP), which uses behavioral science, connected devices, and human coaching to help patients reduce their risk of type 2 diabetes. When GLP-1 prescribing surged, Omada integrated these medications into its existing clinical framework rather than building a standalone prescription mill. The result is one of the most evidence-based, clinically rigorous weight management programs available through telehealth.

Omada primarily operates through employer and health plan partnerships, meaning most patients access the platform at no direct cost — their employer or insurer covers the program fees and, in many cases, the GLP-1 medication itself. This model limits who can enroll (you need to work for a participating employer or be covered by a participating plan), but for those who qualify, the value proposition is extraordinary: brand-name GLP-1 medications, dedicated coaching, and a structured behavior change curriculum at little to no out-of-pocket expense. Check with your HR or benefits department to see if Omada is available to you.

What separates Omada from most telehealth GLP-1 providers is its behavior change methodology. Every patient is paired with a professional health coach and placed into a small peer group for accountability. The program includes lab testing, ongoing metabolic monitoring, registered dietitian access, and a connected smart scale that feeds data directly to your care team. Omada does not simply prescribe medication and check in quarterly — it builds a structured program around the prescription designed to maximize long-term outcomes and reduce the likelihood of weight regain after discontinuation.

Omada holds an A+ rating with the Better Business Bureau, the highest grade available, reflecting strong complaint resolution and business transparency. The company does not have a Trustpilot profile, but its clinical outcomes have been published in peer-reviewed journals, and its DPP program has been recognized by the CDC — a level of institutional validation that few competitors can claim. Omada prescribes brand-name GLP-1 medications (not compounded versions), which means patients receive FDA-approved products manufactured by Novo Nordisk or Eli Lilly.

The primary limitation is access. Because Omada works through employer contracts, individuals without a participating employer cannot simply sign up and pay out of pocket. Additionally, the program’s structured nature — weekly lessons, group check-ins, device syncing — may feel intensive for patients who simply want a prescription. But for those who qualify and are willing to engage, Omada represents the gold standard of integrated GLP-1 care: clinically validated, comprehensively supported, and financially accessible.

Omada Health GLP-1 Medications

At a Glance